- Previous Close
0.0000 - Open
2.2800 - Bid --
- Ask --
- Day's Range
0.5900 - 0.5900 - 52 Week Range
0.0002 - 2.2800 - Volume
100 - Avg. Volume
0 - Market Cap (intraday)
19.976M - Beta (5Y Monthly) 0.05
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0900 - Earnings Date Oct 30, 2024 - Nov 7, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Theraclion SA designs and markets high-tech therapeutic ultrasound equipment. It offers SONOVEIN, a robotic solution for non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment and protects the patient's skin and optimizes the image quality. Theraclion SA was incorporated in 2004 and is based in Malakoff, France.
www.theraclion.comRecent News: TCLIF
View More
Performance Overview: TCLIF
Trailing total returns as of 10/30/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: TCLIF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: TCLIF
View MoreValuation Measures
Market Cap
18.67M
Enterprise Value
12.33M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.01
Price/Book (mrq)
0.00
Enterprise Value/Revenue
9.67
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-93.82%
Return on Assets (ttm)
-12.09%
Return on Equity (ttm)
-118.70%
Revenue (ttm)
3.92M
Net Income Avi to Common (ttm)
-3.67M
Diluted EPS (ttm)
-0.0900
Balance Sheet and Cash Flow
Total Cash (mrq)
7.82M
Total Debt/Equity (mrq)
34.48%
Levered Free Cash Flow (ttm)
--
Company Insights: TCLIF
TCLIF does not have Company Insights